What products does Octapharma offer?

Tolerability and safety in plasma transfusion

Fully pharmaceutically licensed virus-inactivated, standardised Fresh Frozen Plasma (FFP), used to replace clotting factors following major accidents and during surgery as well as for a variety of complex bleeding disorders.

 

Fast & safe restoration of coagulation balance


State-of-the-art 2nd generation human prothrombin complex concentrate offering a haemostatic balance of coagulation factors and inhibitors, used for the prophylaxis and treatment of bleeding and hereditary or acquired coagulation defects resulting from isolated prothrombin complex factor deficiency or combined with prothrombin complex deficiency.

 

New generation VWF/Factor VIII concentrate

 

A new generation von Willebrand Factor /Factor VIII concentrate for the treatment of von Willebrand Disease (VWD) and haemophilia A. wilate® raises the standard in treatment options with respect to its combination of double virus safety, purity and clinical efficacy.

 

Unsurpassed in inhibitor safety - clinically proven1  2

 

Factor VIII/von Willebrand Factor concentrate used to prevent and treat bleeding in persons with haemophilia A (deficiency in clotting Factor VIII). The double virus inactivation, high purity, excellent tolerability and low immunogenicity are particularly important as haemophilia is a chronic condition in which patients require replacement therapy for life.

 

Highly purified native Factor IX

 

octanine F® and nanotiv®
Factor IX concentrates used to prevent and treat bleeding in persons with haemophilia B (deficiency in clotting Factor IX). The virus inactivation, high purity, excellent tolerability, low immunogenicity and lack of thrombogenicity are particularly important as haemophilia is a chronic condition in which patients require replacement therapy for life.

 

High purity 5% IVIG with long-term documented efficacy and tolerability

 

High purity 10% IVIG with proven safety and tolerability at high infusion rates

 

octagam®
State-of-the-art liquid intravenous immunoglobulin (IVIG) for the prevention and treatment of severe, life-threatening infections in patients with primary or secondary immune deficiencies disorders such as HIV and leukaemia. Also used to modify the immune system in auto-immune conditions such as Guillain-Barré Syndrome (GBS) and idiopathic thrombocytopenic purpura (ITP).

 

Albumin – nature’s choice of colloid

Albunorm
Pasteurised protein solution derived from plasma from which clotting factors and immunoglobulins have been removed, used in patients with low plasma protein levels and unstable fluid balance, i.e. during and after surgery, major burns.

 

Safe coagulation control


atenativ®
High-purity, virus-inactivated antithrombin concentrate for treatment of coagulation disturbances in connection with inherited and acquired antithrombin deficiency.

 

Immunoglobulin containing Rh(D) antibodies obtained from immunized donors which prevents hemolytic disease of the newborn

 

rhesonativ®
Virus-inactivated anti-D immunoglobulin used in Rh-negative women during pregnancy to prevent Rhesus immunisation of the mother and the resulting risk of haemolytic disease of the newborn.

 

High purity,  high concentration 16.5% SCIG with low viscosity and long-term documented tolerability 

gammanorm®
SD-treated immunoglobulin for subcutaneous and intramuscular use mainly in patients with primary and secondary immune deficiency.